Abstract:A systematic engineering of Escherichia coli BL21 (DE3) isoprenoid and central carbon pathways, coupled with translational and protein engineering of a sesquiterpene synthase from Nostoc sp. PCC 7120 yielded high‐efficient β‐elemene production. β‐elemene is one of the most commonly used antineoplastic drugs in cancer treatment. As a plant‐derived natural chemical, biologically engineering microorganisms to produce germacrene A to be converted to β‐elemene harbors great expectations since chemical synthesis and plant isolation methods come with their production deficiencies. In this study, we report the design of an Escherichia coli cell factory for the de novo production of germacrene A to be converted to β‐elemene from a simple carbon source. A series of systematic approaches of engineering the isoprenoid and central carbon pathways, translational and protein engineering of the sesquiterpene synthase, and exporter engineering yielded high‐efficient β‐elemene production. Specifically, deleting competing pathways in the central carbon pathway ensured the availability of acetyl‐coA, pyruvate, and glyceraldehyde‐3‐phosphate for the isoprenoid pathways. Adopting lycopene color as a high throughput screening method, an optimized NSY305N was obtained via error‐prone polymerase chain reaction mutagenesis. Further overexpression of key pathway enzymes, exporter genes, and translational engineering produced 1161.09 mg/L of β‐elemene in a shake flask. Finally, we detected the highest reported titer of 3.52 g/L of β‐elemene and 2.13 g/L germacrene A produced by an E. coli cell factory in a 4‐L fed‐batch fermentation. The systematic engineering reported here generally applies to microbial production of a broader range of chemicals. This illustrates that rewiring E. coli central metabolism is viable for producing acetyl‐coA‐derived and pyruvate‐derived molecules cost‐effectively.

Engineering yeast for high-level production of diterpenoid sclareol

Engineered Microbial Consortium for De Novo Production of Sclareolide

Efficient Biotransformation of Sclareol to Sclareolide by Filobasidium Magnum JD1025

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

High-level Production of Linalool by Engineered Saccharomyces Cerevisiae Harboring Dual Mevalonate Pathways in Mitochondria and Cytoplasm.

Construction of an Artificial Microbial Consortium for Green Production of (−)-Ambroxide

Engineering Saccharomyces cerevisiae for enhanced (–)-α-bisabolol production

Engineering Sclareol Production on the Leaf Surface of Nicotiana tabacum

High-titer production of 13R-manoyl oxide in metabolically engineered Saccharomyces cerevisiae

Renewable Fatty Acid Ester Production in Clostridium.

Exploring engineering strategies that enhance de novo production of exotic cyclopropane fatty acids in Saccharomyces cerevisiae

Genetic and bioprocess engineering to improve squalene production in Yarrowia lipolytica

Systematic Engineering to Enhance β-Myrcene Production in Yeast

Engineering Escherichia coli BL21 (DE3) for high‐yield production of germacrene A, a precursor of β‐elemene via combinatorial metabolic engineering strategies

Engineering Saccharomyces cerevisiae for high-efficient production of ursolic acid via cofactor engineering and acetyl-CoA optimization

Engineering Escherichia coli via introduction of the isopentenol utilization pathway to effectively produce geranyllinalool

Establishing cell suitability for high-level production of licorice triterpenoids in yeast

Comparative Proteomic Analyses of Hyphozyma Roseonigra ATCC 20624 in Response to Sclareol

Metabolic engineering of Yarrowia lipolytica for high-level production of squalene

Engineering sub-organelles of a diploid Saccharomyces cerevisiae to enhance the production of 7-dehydrocholesterol

Systems Metabolic Engineering of Saccharomyces cerevisiae for the High-Level Production of (2S)-Eriodictyol